Plain-English translation of NCT03635255 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for tiny molecules in your blood called microRNAs that might help predict whether someone with heart disease will have serious problems in the future. By studying these blood markers, doctors hope to better understand who is at highest risk and how to prevent complications before they happen.
Right now, doctors don't have a reliable blood test to predict which patients with heart disease will develop serious complications. This study aims to find new blood markers that could give doctors an early warning system, allowing them to provide better care and prevent heart attacks or other emergencies.
You likely qualify if…
You likely don't qualify if…
You will have a blood sample drawn, which the researchers will analyze to look for these special blood markers. The study is observational, meaning you won't be given a new medication or treatment — just one blood draw. Researchers will likely follow your health over time to see whether the blood markers they find are accurate at predicting future heart problems.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Taiwan
Enrollment target
~460 participants
Started
September 2019
Primary completion
June 2027
Age range
20 Years and older
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chau chung Wu, PhD
National Taiwan University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.